Clinical Trial Update: Intra-articular Tranexamic Acid in the Reduction of Blood Transfusions in Primary Total Hip and Total Knee Arthroplasty [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intra-articular tranexamic acid to reduce blood transfusions in primary total hip and total knee arthroplasty has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Orthopaedic Innovation Centre | Conditions: Osteoarthritis | Phase 2 | Status: COMPLETED